Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-12-30

Clinical Trial Update: Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: [Phase 4]

View source ↗

Summary

A Phase 4 trial update concerning withdrawal of pharmacological treatment in patients who respond to cardiac resynchronization therapy (CRT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN